Seth Kroll
@sethkroll.bsky.social
Amateur photographer, lifelong dog-lover, micro-mobility enthusiast, Bostonian-by-choice. Also, communications at Wyss Institute at Harvard University.
Harvard scientists published thousands of studies in 2025, advancing knowledge and discovering solutions in a time when research funding is uncertain.
www.harvard.edu/in-focus/bre...
www.harvard.edu/in-focus/bre...
Breakthroughs of 2025 - Harvard University
Harvard scientists published thousands of studies in 2025, advancing knowledge and discovering solutions in a time when research funding is uncertain.
www.harvard.edu
December 10, 2025 at 2:42 PM
Harvard scientists published thousands of studies in 2025, advancing knowledge and discovering solutions in a time when research funding is uncertain.
www.harvard.edu/in-focus/bre...
www.harvard.edu/in-focus/bre...
Reposted by Seth Kroll
Learn how federal funds fuel life-saving innovations by following three Wyss projects from government grant to technology development to patient impact, powered by The Wyss Effect: core scientific breakthroughs that move science forward to create a positive impact for life on earth.
How federal funds fuel life-saving innovation
Why has the U.S. government historically awarded grants for fundamental research when the results aren’t guaranteed to have near-term societal impact? This topic has gotten much attention in recent mo...
wyss.harvard.edu
December 9, 2025 at 4:38 PM
Learn how federal funds fuel life-saving innovations by following three Wyss projects from government grant to technology development to patient impact, powered by The Wyss Effect: core scientific breakthroughs that move science forward to create a positive impact for life on earth.
Reposted by Seth Kroll
The destruction of the enterprise of US academic science has been one of the most confounding aspects of a hugely confounding year. My @statnews.com colleagues are writing about the consequences for individuals & the country.
You want to read this series.
www.statnews.com/american-sci...
You want to read this series.
www.statnews.com/american-sci...
American Science, Shattered
An eight-decade partnership between universities and the federal government made U.S. science preeminent. It took Trump less than a year to shred that
www.statnews.com
December 9, 2025 at 5:23 PM
The destruction of the enterprise of US academic science has been one of the most confounding aspects of a hugely confounding year. My @statnews.com colleagues are writing about the consequences for individuals & the country.
You want to read this series.
www.statnews.com/american-sci...
You want to read this series.
www.statnews.com/american-sci...
Reposted by Seth Kroll
We are thrilled to announce the appointment of three new Associate Faculty members: Ahmad (Mo) Khalil, Jarad Mason, and Chao-ting (Ting) Wu.
Wyss Institute appoints three new Associate Faculty members: Ahmad Khalil, Jarad Mason, and Ting Wu
By Jessica Leff The Wyss Institute is proud to welcome three new Associate Faculty members: Ahmad (Mo) Khalil, Ph.D., Jarad Mason, Ph.D., and Chao-ting (Ting) Wu, Ph.D. Each has a history of collabora...
wyss.harvard.edu
December 8, 2025 at 4:15 PM
We are thrilled to announce the appointment of three new Associate Faculty members: Ahmad (Mo) Khalil, Jarad Mason, and Chao-ting (Ting) Wu.
Reposted by Seth Kroll
For the first time this century, the number of children worldwide who die before their fifth birthday is projected to rise, according to a new study published by the Gates Foundation.
Child deaths under 5 believed to be rising for first time in decades
Cuts to development aid from several countries is a key factor, researchers said.
www.washingtonpost.com
December 8, 2025 at 10:00 AM
For the first time this century, the number of children worldwide who die before their fifth birthday is projected to rise, according to a new study published by the Gates Foundation.
Reposted by Seth Kroll
In this episode of Grow Everything, the hosts speak to Associate Faculty member Michael Levin about how cells make decisions without brains, store memories without DNA, and navigate anatomical space like we navigate physical space.
When Matter Makes Decisions: Michael Levin on the Intelligence of Form
In this episode of Grow Everything, hosts Karl Schmieder and Erum Azeez Khan have a conversation with Professor Michael Levin, Ph.D., Wyss Associate Faculty member and the Director of the Allen Discov...
wyss.harvard.edu
December 5, 2025 at 4:02 PM
In this episode of Grow Everything, the hosts speak to Associate Faculty member Michael Levin about how cells make decisions without brains, store memories without DNA, and navigate anatomical space like we navigate physical space.
Reposted by Seth Kroll
Congestion pricing in NYC has worked and has become popular. Cities like Boston should follow.
www.bostonglobe.com/2025/12/05/o...
www.bostonglobe.com/2025/12/05/o...
Three takeaways for Boston from NYC’s congestion pricing scheme - The Boston Globe
After a year of the first American program of its kind, there’s enough data to recommend the idea.
www.bostonglobe.com
December 5, 2025 at 12:47 PM
Congestion pricing in NYC has worked and has become popular. Cities like Boston should follow.
www.bostonglobe.com/2025/12/05/o...
www.bostonglobe.com/2025/12/05/o...
It’s not the fuel efficiency of these cars that’s the major concern, but the safety of those rear-facing seats. Loved them as a kid, the “backy back,” as my brother and I would call them, but no way would I put my kids back there (consumer choice)
Sean Duffy on slashing fuel economy standards: "This rule will actually allow you to bring back the 1970s station wagon. Maybe a little wood paneling on the side. We can bring back choice to consumers."
December 4, 2025 at 11:56 PM
It’s not the fuel efficiency of these cars that’s the major concern, but the safety of those rear-facing seats. Loved them as a kid, the “backy back,” as my brother and I would call them, but no way would I put my kids back there (consumer choice)
Jim Collins (MIT & @wyssinstitute.bsky.social) is using generative AI to design new antibiotic molecules. Early candidates have shown ability to kill drug-resistant bacteria, including MRSA and drug-resistant gonorrhea. It’s still early work, but promising.
fastcompany.co.za/tech/2025-12...
fastcompany.co.za/tech/2025-12...
MIT is leveraging AI to create new antibiotics
Discover how MIT scientists are harnessing AI to design new antibiotics from scratch, addressing the urgent challenge of antibiotic resistance and paving the way for innovative medical solutions.
fastcompany.co.za
December 3, 2025 at 2:04 PM
Jim Collins (MIT & @wyssinstitute.bsky.social) is using generative AI to design new antibiotic molecules. Early candidates have shown ability to kill drug-resistant bacteria, including MRSA and drug-resistant gonorrhea. It’s still early work, but promising.
fastcompany.co.za/tech/2025-12...
fastcompany.co.za/tech/2025-12...
Reposted by Seth Kroll
Don Ingber’s team at the Wyss Institute is collaborating with researchers at the University of Newcastle, Australia, to develop a world-first stroke therapy. A new publication in Advanced Science demonstrates how their approach works.
Buying time for more stroke patients
www.newcastle.edu.au
December 2, 2025 at 4:10 PM
Don Ingber’s team at the Wyss Institute is collaborating with researchers at the University of Newcastle, Australia, to develop a world-first stroke therapy. A new publication in Advanced Science demonstrates how their approach works.
Reposted by Seth Kroll
New York Times article on science funding with some depressing but familiar curves with interactive graphics.
www.nytimes.com/interactive/...
www.nytimes.com/interactive/...
The U.S. Is Funding Fewer Grants in Every Area of Science and Medicine (Gift Article)
A quiet policy change means the government is making fewer bets on long-term science.
www.nytimes.com
December 2, 2025 at 11:57 AM
New York Times article on science funding with some depressing but familiar curves with interactive graphics.
www.nytimes.com/interactive/...
www.nytimes.com/interactive/...
Reposted by Seth Kroll
America’s next wave of scientific talent may come from Lambert High School, where students used CRISPR to develop a promising new way to detect and treat Lyme disease. This Sunday, Bill Whitaker follows the students as they compete in a prestigious international science competition. 60Minutes.com
November 26, 2025 at 4:00 PM
America’s next wave of scientific talent may come from Lambert High School, where students used CRISPR to develop a promising new way to detect and treat Lyme disease. This Sunday, Bill Whitaker follows the students as they compete in a prestigious international science competition. 60Minutes.com
Reposted by Seth Kroll
Fighting food waste seems like a good use of machine learning.
Meet Pancho, the AI bot fighting food waste at the hotel buffet
Spanish hoteliers are turning to technology to avoid fines for tossing out up to 30 per cent of lavish daily spreads
www.thetimes.com
November 24, 2025 at 11:25 AM
Fighting food waste seems like a good use of machine learning.
Reposted by Seth Kroll
Did you know that Ellen Roche used to train for triathlons?
Ellen Roche is an Associate Faculty member of the Wyss and the Latham Family Career Development Professor at the Department of Mechanical Engineering and the IMES at MIT.
Learn more about her in this #Wyss20ishQs.
Ellen Roche is an Associate Faculty member of the Wyss and the Latham Family Career Development Professor at the Department of Mechanical Engineering and the IMES at MIT.
Learn more about her in this #Wyss20ishQs.
20-ish Questions with Ellen Roche
20-ish Questions shows a different side of Wyss Institute faculty, touching on aspects of their personal life, hobbies, interests, as well as their research. This round follows Ellen Roche, an Associa...
wyss.harvard.edu
November 24, 2025 at 4:51 PM
Did you know that Ellen Roche used to train for triathlons?
Ellen Roche is an Associate Faculty member of the Wyss and the Latham Family Career Development Professor at the Department of Mechanical Engineering and the IMES at MIT.
Learn more about her in this #Wyss20ishQs.
Ellen Roche is an Associate Faculty member of the Wyss and the Latham Family Career Development Professor at the Department of Mechanical Engineering and the IMES at MIT.
Learn more about her in this #Wyss20ishQs.
Reposted by Seth Kroll
Our study of time processing in bumblebees 🐝 covered by @cnn.com here edition.cnn.com/2025/11/12/s... . Our summary is here youtu.be/hsGxU65OMQk and the original paper royalsocietypublishing.org/doi/full/10.... @royalsocietypublishing.org
Scientists now know that bees can process time, a first in insects | CNN
Bumblebees can process the duration of flashes of light and use the information to decide where to look for food, a new study has found.
edition.cnn.com
November 22, 2025 at 1:04 PM
Our study of time processing in bumblebees 🐝 covered by @cnn.com here edition.cnn.com/2025/11/12/s... . Our summary is here youtu.be/hsGxU65OMQk and the original paper royalsocietypublishing.org/doi/full/10.... @royalsocietypublishing.org
Reposted by Seth Kroll
Gina Wang approaches baking the same way she approaches science. The difference is that, in her research, she doesn't have a recipe. She’s making a novel device that could be used to monitor the progression of, and one day diagnose, ALS. Learn more about Gina and her work in this month’s #HOWyss.
Gina Wang on having the NERVE to detect ALS
The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and be...
wyss.harvard.edu
November 21, 2025 at 4:32 PM
Gina Wang approaches baking the same way she approaches science. The difference is that, in her research, she doesn't have a recipe. She’s making a novel device that could be used to monitor the progression of, and one day diagnose, ALS. Learn more about Gina and her work in this month’s #HOWyss.
Reposted by Seth Kroll
Why has the U.S. government historically awarded grants for fundamental research?
While there’s no guarantee of immediate public benefit, crucial early-stage discoveries spawn developments that have real-world impact.
Follow three projects from government grant to patient impact.
While there’s no guarantee of immediate public benefit, crucial early-stage discoveries spawn developments that have real-world impact.
Follow three projects from government grant to patient impact.
How federal funds fuel life-saving innovation
Why has the U.S. government historically awarded grants for fundamental research when the results aren’t guaranteed to have near-term societal impact? This topic has gotten much attention in recent mo...
wyss.harvard.edu
November 20, 2025 at 6:01 PM
Why has the U.S. government historically awarded grants for fundamental research?
While there’s no guarantee of immediate public benefit, crucial early-stage discoveries spawn developments that have real-world impact.
Follow three projects from government grant to patient impact.
While there’s no guarantee of immediate public benefit, crucial early-stage discoveries spawn developments that have real-world impact.
Follow three projects from government grant to patient impact.
Reposted by Seth Kroll
We've seen some remarkable outcomes in people with advanced, refractory cancers, including pancreatic, melanoma, and renal, with personalized neoantigen mRNA vaccines.
But this work is now endangered.
www.scientificamerican.com/article/pers...
But this work is now endangered.
www.scientificamerican.com/article/pers...
November 18, 2025 at 7:16 PM
We've seen some remarkable outcomes in people with advanced, refractory cancers, including pancreatic, melanoma, and renal, with personalized neoantigen mRNA vaccines.
But this work is now endangered.
www.scientificamerican.com/article/pers...
But this work is now endangered.
www.scientificamerican.com/article/pers...
Reposted by Seth Kroll
"Delivering biologic drugs across the blood-brain barrier now seems achievable," explains Jim Gorman, Wyss Senior Director of Translational R&D and PI for the Brain Targeting Program.
Learn more about this exciting program, its progress, and how you can get involved.
Learn more about this exciting program, its progress, and how you can get involved.
Crossing the barrier: Wyss Brain Targeting Program is delivering on its promise
By Seth Kroll (BOSTON) — Launched in 2019 as an ambitious idea, the Wyss Brain Targeting Program was designed to address a critical challenge in neuroscience and brain health: how to safely and effect...
wyss.harvard.edu
November 13, 2025 at 4:37 PM
"Delivering biologic drugs across the blood-brain barrier now seems achievable," explains Jim Gorman, Wyss Senior Director of Translational R&D and PI for the Brain Targeting Program.
Learn more about this exciting program, its progress, and how you can get involved.
Learn more about this exciting program, its progress, and how you can get involved.
Reposted by Seth Kroll
Wyss and @brighamandwomens.bsky.social researchers have developed a novel RNA therapy that overrides an immune-suppressive function in tumor cells to re-engage the immune system in complex tumors. @pnas.org
Beating cancer cells at their own game by stepping on their cGAS
By Benjamin Boettner (BOSTON) — Cancer cells develop various strategies to paralyze immune cells to evade their attack in the complex tumor microenvironment (TME). Using one such strategy, they crippl...
wyss.harvard.edu
November 12, 2025 at 5:47 PM
Wyss and @brighamandwomens.bsky.social researchers have developed a novel RNA therapy that overrides an immune-suppressive function in tumor cells to re-engage the immune system in complex tumors. @pnas.org
Reposted by Seth Kroll
⚡ Breaking: FDA unveils new pathway for personalized therapies
FDA unveils new path to speed personalized therapies, inspired by Baby KJ
FDA Commissioner Marty Makary and CBER Director Vinay Prasad laid out how drugmakers can reuse technology and earlier data from past efforts to streamline future regulatory reviews.
endpoints.news
November 12, 2025 at 10:18 PM
⚡ Breaking: FDA unveils new pathway for personalized therapies
Reposted by Seth Kroll
Wyss Founding Director, Donald Ingber was featured in last night's episode of @60minutes.bsky.social as part of a segment on funding cuts to Harvard and science in general. Ingber, along with other Harvard faculty, spoke about how their potentially life-saving advances have been jeopardized.
What's at risk when federal research funding to universities is cut | 60 Minutes
Federal research funding to universities has fueled breakthroughs for years. The White House is pressuring universities to align with the president's political agenda, or risk losing their funding.
www.cbsnews.com
November 10, 2025 at 4:23 PM
Wyss Founding Director, Donald Ingber was featured in last night's episode of @60minutes.bsky.social as part of a segment on funding cuts to Harvard and science in general. Ingber, along with other Harvard faculty, spoke about how their potentially life-saving advances have been jeopardized.
On @60minutes.bsky.social, the @wyssinstitute.bsky.social's Don Ingber spoke about how shrinking federal research support risks American leadership in developing life-saving medical breakthroughs that could potentially save any one of us or our loved ones.
www.cbsnews.com/video/federa...
www.cbsnews.com/video/federa...
What's at risk when federal research funding to universities is cut | 60 Minutes
Federal research funding to universities has fueled breakthroughs for years. The White House is pressuring universities to align with the president's political agenda, or risk losing their funding.
www.cbsnews.com
November 10, 2025 at 2:37 PM
On @60minutes.bsky.social, the @wyssinstitute.bsky.social's Don Ingber spoke about how shrinking federal research support risks American leadership in developing life-saving medical breakthroughs that could potentially save any one of us or our loved ones.
www.cbsnews.com/video/federa...
www.cbsnews.com/video/federa...
Reposted by Seth Kroll
Blood Clot Dx is a microfluidic chip device that can non-invasively monitor a patient’s blood for evidence of clotting in real time. The first application will be in patients with MPM, an aggressive lung cancer. Eventually, this could be used to detect blood clots in a variety of contexts.
Blood Clot Dx
An ultra-sensitive triage test that identifies patients at risk for blood clots before they happen, enabling proactive treatment to reduce complications and deaths across a wide range of conditions.
buff.ly
November 8, 2025 at 3:59 PM
Blood Clot Dx is a microfluidic chip device that can non-invasively monitor a patient’s blood for evidence of clotting in real time. The first application will be in patients with MPM, an aggressive lung cancer. Eventually, this could be used to detect blood clots in a variety of contexts.